Titan Pharmaceuticals, Inc. (OTCBB: TTNP) announced that it has contracted with Deerfield Management to supply Titan with $20 million in financing. Funding is anticipated to be available on about April 4, 2011.
Titan is the manufacturer of the Probuphine implant for the treatment of opiate dependence.
Filed under: Uncategorized
Recovery Helpdesk 